During the past decade, Manchester Memorial Hospital conducted 6 clinical trials. In the 10-year time frame, 6 clinical trials started and 21 clinical trials were completed, i.e. on average, 350% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 7 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Manchester Memorial Hospital" #1 sponsor was "National Cancer Institute (NCI)" with 21 trials, followed by "SWOG Cancer Research Network" with 4 trials sponsored, "NSABP Foundation Inc" with 3 trials sponsored, "Alliance for Clinical Trials in Oncology" with 2 trials sponsored and "ECOG-ACRIN Cancer Research Group" with 2 trials sponsored. Other sponsors include -3 different institutions and companies that sponsored additional 7 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Manchester Memorial Hospital" #1 collaborator was "National Cancer Institute (NCI)" with 12 trials as a collaborator, "Cancer and Leukemia Group B" with 2 trials as a collaborator, "NCIC Clinical Trials Group" with 2 trials as a collaborator, "NRG Oncology" with 2 trials as a collaborator and "SWOG Cancer Research Network" with 2 trials as a collaborator. Other collaborators include 2 different institutions and companies that were collaborators in the rest 12 trials.

According to Clinical.Site data, the most researched conditions in "Manchester Memorial Hospital" are "Breast Cancer" (4 trials), "Stage IIA Breast Cancer AJCC v6 and v7" (4 trials), "Stage IIB Breast Cancer AJCC v6 and v7" (4 trials), "Stage IIIA Breast Cancer AJCC v7" (4 trials) and "Breast Adenocarcinoma" (3 trials). Many other conditions were trialed in "Manchester Memorial Hospital" in a lesser frequency.

Most popular intervention types in "Manchester Memorial Hospital" are "Drug" (25 trials), "Other" (21 trials), "Biological" (16 trials), "Procedure" (4 trials) and "Behavioral" (1 trials). Other intervention types were less common.

The name of intervention was led by "Laboratory Biomarker Analysis" (12 trials), "Quality-of-Life Assessment" (7 trials), "Paclitaxel" (6 trials), "Bevacizumab" (4 trials) and "Clinical Observation" (4 trials). Other intervention names were less common.

The vast majority of trials in "Manchester Memorial Hospital" are 24 trials for "All" genders, 8 trials for "Female" genders and 2 trials for "Male" genders.

Currently, there are NaN active trials in "Manchester Memorial Hospital". undefined are not yet recruiting, 2 are recruiting, 15 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 15 completed trials in Manchester Memorial Hospital, undefined suspended trials, and 2 terminated clinical trials to date.

Out of the total trials that were conducted in Manchester Memorial Hospital, 0 "Phase 1" clinical trials were conducted, 7 "Phase 2" clinical trials and 25 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 2 trials that are defined as “Not Applicable".

Manchester Memorial Hospital has several departments that took part in Clinical trials: "DeQuattro Community Cancer Center" - 2 trials